Table 3 Clinical outcomes up to 3 years follow-up
Endpoint | 0–1 year n (%) | 1–2 year n (%) | 2–3 year n (%) | 0–3 years n (%) |
|---|---|---|---|---|
Target lesion failure | 76 (3.1%) | 57 (2.3%) | 35 (1.4%) | 168 (6.8%) |
Cardiac death | 44 (1.8%) | 24 (1.0%) | 26 (1.0%) | 94 (3.8%) |
Target non-fatal vessel MI | 9 (0.4%) | 6 (0.2%) | 3 (0.1%) | 18 (0.7%) |
Clinically driven TLR | 34 (1.3%) | 30 (1.2%) | 9 (0.4%) | 73 (2.9%) |
Definite stent thrombosis | 5 (0.2%) | 0 (0%) | 1 (0.04%) | 6 (0.2%) |
Definite/Probable stent thrombosis | 10 (0.4%) | 2 (0.1%) | 1 (0.04%) | 13 (0.5%) |